SCHEMBL19081898

SCHEMBL19081898

c1ccc(-c2c3ccccc3c(-c3ccc(-c4cc5c6ccccc6oc5c5c4sc4cc6ccccc6cc45)cc3)c3ccccc23)cc1

nearest known ligand 0.34

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ESR1 P03372 2/20 0.34
ESR2 Q92731 2/20 0.34
ADORA2A P29274 1/20 0.34
ALOX5 P09917 1/20 0.33
CDC14B O60729 1/20 0.32
CDC14A Q9UNH5 1/20 0.32
KDM4E B2RXH2 3/20 0.32
ALDH1A1 P00352 2/20 0.32
RAB9A P51151 2/20 0.32
AHR P35869 1/20 0.32
MAOB P27338 1/20 0.32
KMT2A Q03164 2/20 0.30
GAA P10253 2/20 0.30
HSD17B10 Q99714 2/20 0.30
MEN1 O00255 1/20 0.30
CYP3A4 P08684 1/20 0.30
ALPI P09923 1/20 0.30
MAPT P10636 1/20 0.30
PKM P14618 1/20 0.30
HPGD P15428 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19082026 0.95 ALOX5 (0.33) ESR1ESR2ADORA2AALOX5KDM4E
SCHEMBL19081967 0.94 NPC1 (0.33) ALOX5RAB9AAHRNPC1CYP1A2
SCHEMBL19081934 0.92 ALOX5 (0.35) ALOX5
SCHEMBL19081801 0.88 NPC1 (0.34) ALOX5RAB9AAHRNPC1CYP1A2
SCHEMBL19081843 0.86 ALOX5 (0.32) ALOX5RAB9APLA2G2APLA2G4ANPC1
SCHEMBL19082061 0.86 ALOX5 (0.36) ALOX5
SCHEMBL19081797 0.83 ALOX5 (0.34) ESR1ESR2ALOX5KDM4EALDH1A1
SCHEMBL17944373 0.81 ESR2 (0.39) ESR1ESR2ADORA2AALOX5CDC14B
SCHEMBL19081832 0.81 ESR1 (0.33) ESR1ESR2ADORA2AALOX5CDC14B
SCHEMBL19081503 0.81 KDM4E (0.39) ESR1ESR2ADORA2AALOX5CDC14B

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10553800-B2 Condensed cyclic compound and an organic light-emitting device including the same SAMSUNG DISPLAY CO., LTD. (KR) 2020-02-04 US disclosed
US-20170194572-A1 CONDENSED CYCLIC COMPOUND AND AN ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME SAMSUNG DISPLAY CO., LTD. (KR) 2017-07-06 US disclosed
US-20170194572-A1 CONDENSED CYCLIC COMPOUND AND AN ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME SAMSUNG DISPLAY CO., LTD. (KR) 2017-07-06 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10553800-B2 Condensed cyclic compound and an organic light-emitting device including the same CRY1, CRY2, CCNT1 ESR1 225/4885ESR2 542/4885ADORA2A 4716/4885
US-20170194572-A1 CONDENSED CYCLIC COMPOUND AND AN ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME CRY1, CRY2, CCNT1 ESR1 225/4885ESR2 542/4885ADORA2A 4716/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.